---
title: "Winner Medical: Operating profit margin is expected to increase year-on-year in 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242853115.md"
description: "Winner Medical stated in an institutional research that it expects the operating profit margin to increase year-on-year in 2025. The operating profit margin for the medical business in 2024 is 7.6%, while for All Cotton Era it is 12.1%. With the end of the impact from public health events, the destocking and capacity reduction of protective products have been completed, and the profit margin of the medical business is expected to improve. At the same time, the brand momentum of All Cotton Era is rising, consumer recognition is increasing, product structure is being optimized, and the gross profit margin outlook is positive, leading to an overall increase in the operating profit margin of the consumer goods business"
datetime: "2025-06-03T02:35:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242853115.md)
  - [en](https://longbridge.com/en/news/242853115.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242853115.md)
generator: "portal-rs"
---

# Winner Medical: Operating profit margin is expected to increase year-on-year in 2025

Winner Medical recently stated during an institutional research that by 2025, the overall profitability of the company's two main businesses is expected to show a steady improvement. In 2024, the overall operating profit margin of the medical business is projected to be 7.6%; the operating profit margin of Cotton Era is expected to be 12.1%, continuing to rise since 2022. Looking ahead to 2025, the phase affected by public health events for the medical business has basically ended, and the destocking and capacity reduction of protective products have been completed, with the operating profit margin expected to increase year-on-year. The brand momentum of Cotton Era is rising, consumer recognition is improving, product structure is optimized, and the results of cost reduction and efficiency enhancement are significant, with a positive outlook for gross profit margin; marketing investments are becoming more precise, and management expense ratios are expected to decline, with the overall operating profit margin of the consumer goods business likely to continue to improve

### Related Stocks

- [300888.CN](https://longbridge.com/en/quote/300888.CN.md)

## Related News & Research

- [REG - On the Beach Group - Holding(s) in Company](https://longbridge.com/en/news/296936991.md)
- [Adaptyv Bio raises $40 million Series A as ACE Ventures joins round](https://longbridge.com/en/news/297004059.md)
- [ARX Equity Partners acquires majority stake in Slovenia physiotherapy provider Medicofit](https://longbridge.com/en/news/296993661.md)
- [RCS - ZAGENO - ZAGENO and ORO Labs Partnership](https://longbridge.com/en/news/297046609.md)
- [Eden Research Reports Revenue Of £4.90 Million For 15 Months Ended 31 March 2026](https://longbridge.com/en/news/296994948.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**